Doctors were left astonished after an experimental cancer drug appeared to cure every patient during a clinical trial.
Dostarlimab was given to 18 patients with a certain type of rectal cancer every three weeks for six months in a study at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, America.
The drug appeared to remove the rectal cancer from the patients' bodies with minimal side effects although scientists are saying it is too early to say if the patients are totally cured, reports the Mirror.
